Xtant Medical Holdings (XTNT) Interest & Investment Income (2023)

Xtant Medical Holdings (XTNT) reported Interest & Investment Income of $16000.0 for Q4 2023, down 66.67% quarter-over-quarter from $48000.0 in Q3 2023.

Xtant Medical Holdings (XTNT) Interest & Investment Income (2023) Analysis & Trends

Xtant Medical Holdings (XTNT) has 1 years of Interest & Investment Income data on file, last reported at $16000.0 in Q4 2023.

  • Interest & Investment Income for Q4 2023 came in at $16000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $149000.0 (changed N/A YoY), and the FY2023 annual result was $149000.0, up 380.65% from the prior year.
  • Interest & Investment Income eased to $16000.0 in Q4 2023 per XTNT's latest filing, from $48000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $86000.0 in Q1 2023 and troughed at -$1000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 106.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 33.50 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 40.98 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Xtant Medical Holdings 62.75 Mn 45.42 Mn 17.75 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 16,000.00
Sep 30, 2023 48,000.00
Jun 30, 2023 -1,000.00
Mar 31, 2023 86,000.00